Improved survival in patients with refractory glioblastoma that response to Irinotecan and Bevacizumab

  1. Hernandez-Jorge, A.
  2. Reyna, C.
  3. Espinos, J.
  4. de la Cruz, S.
  5. Santisteban, M.
  6. Fernandez-Hidalgo, O.
  7. Aramendia, J. M.
  8. Aristu, J. J.
  9. Garcia-Foncillas, J.
Aldizkaria:
EJC SUPPLEMENTS

ISSN: 1359-6349

Argitalpen urtea: 2009

Alea: 7

Zenbakia: 2

Orrialdeak: 499-499

Biltzarra: 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology

Mota: Biltzar ekarpena

DOI: 10.1016/S1359-6349(09)71694-5 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak

Datuen iturria: WoS